Acasti Pharma NASDAQ ACST
$3.03 0.18 5.94%
Today share price
Canada
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

34.86M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

7.06M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.51
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

11.51M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

4.84 %
Upcoming events Acasti Pharma All events
No upcoming events scheduled

Stock chart Acasti Pharma

Stock analysis Acasti Pharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.89 35.52
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.51 13.63
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.39 17.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-1.53 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-60.64 8.90

Price change Acasti Pharma per year

1.44$ 9.76$
Min Max

Summary analysis Acasti Pharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Acasti Pharma

Revenue and net income Acasti Pharma

All parameters

About company Acasti Pharma

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Address:
3009 boulevard de la Concorde East, Laval, QC, Canada, H7E 2B5
Company name: Acasti Pharma
Issuer ticker: ACST
ISIN: CA00430K8730
Country: Canada
Exchange: NASDAQ
Currency: $
IPO date: 2011-05-06
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.acastipharma.com

On which stock exchange are Acasti Pharma (ACST) stocks traded?

Acasti Pharma (ACST) stocks are traded on NASDAQ.

What is the ticker of Acasti Pharma stocks (ACST)?

The stock ticker of Acasti Pharma’s stocks or in other words, the code is ACST. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Acasti Pharma (ACST) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Acasti Pharma (ACST) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Acasti Pharma (ACST) stocks traded?

Acasti Pharma (ACST) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Acasti Pharma (ACST) stocks today?

The current price of Acasti Pharma stocks on 03.05.2024 is 3.03 dollars. per share.

What is the dynamics of Acasti Pharma (ACST) stocks from the beginning of the year?

Acasti Pharma (ACST) quotes have increased by 9.78% from the beginning of the year up to 3.03 dollars. per 1 stocks.

How much did Acasti Pharma (ACST) stocks increase in мае 2024?

This month Acasti Pharma (ACST) quotes have increased by 6.31% to 3.03 dollars. per share.

How much are Acasti Pharma (ACST) stocks worth?

Today, on October, 03.05.2024 Acasti Pharma’s (ACST) stocks cost 3.03 dollars..

What is the market capitalization of Acasti Pharma (ACST)?

Capitalization is the market value of Acasti Pharma (ACST) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 03.05.2024, the market capitalization of Acasti Pharma (ACST) is estimated at about 34863959 dollars.